Search

everythinglearnresearchcommunity

for

Search:↓

Most patients were satisfied with topical finasteride, and few experienced side effects.

Local corticosteroids can help with alopecia areata, but hair loss often returns after stopping treatment.

Microneedling with PRP is as effective and safe as minoxidil+finasteride for treating hair loss.

Topical finasteride is well-tolerated and satisfies most users with minimal side effects.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Combining online and in-person dermatology care can improve quality and access.

Alopecia areata and its severe forms are becoming more common, especially among females, adults, and people in the Northeast.

A male with aromatase deficiency improved bone health with estradiol treatment.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

More research is needed to improve telemedicine in primary care.

Female-marketed minoxidil foam is more expensive than male-marketed, but generic and bulk options can reduce this gap.

Upadacitinib effectively treats severe alopecia areata and is safe.

Darker hair colors may increase the risk of alopecia areata, while lighter hair colors may decrease it.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

The document is a detailed medical reference on skin and genetic disorders.

The Asiatic lion has very low genetic diversity and unique genetic traits, highlighting the need for its conservation.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

People often have negative attitudes toward those with alopecia, especially if it's severe or seen as a medical issue.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Mutations in the SNRPE gene cause hereditary hair loss.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

A new mutation in the KRT86 gene was found to cause the hair disorder monilethrix in a Han family.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

More severe alopecia areata can lower quality of life.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Significant, lasting hair regrowth is needed to improve how patients with Alopecia Areata feel about their condition.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

New mutations in hair keratin genes cause the rare hair disorder monilethrix.